| Kaysville Clinic, Llc | |
|
934 S Main Layton UT 84041-4250 | |
| (801) 544-4227 | |
| (801) 544-3724 |
| Full Name | Kaysville Clinic, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 934 S Main, Layton, Utah |
| Authorized Official Name and Position | Layne K Kamalu (OWNER) |
| Authorized Official Contact | 8015444227 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Kaysville Clinic, Llc 934 S Main Layton UT 84041-4250 Ph: (801) 544-4227 | Kaysville Clinic, Llc 934 S Main Layton UT 84041-4250 Ph: (801) 544-4227 |
| NPI Number | 1013047521 |
|---|---|
| Provider Enumeration Date | 03/06/2007 |
| Last Update Date | 10/26/2007 |
| Medicare PECOS PAC ID | 2264331636 |
|---|---|
| Medicare Enrollment ID | O20040105000589 |
News Archive
Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.
Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
Chemists funded by NIH's National Institute of General Medical Sciences are working to develop "greener" processes for discovering, developing and manufacturing medicines and other molecules with therapeutic potential, as well as compounds used in biomedical research.
A new University of Sydney study has found that having Type 1 diabetes alters the normal communication between the human central nervous system and bone marrow, causing inflammatory effects and further disease.
A three year old girl is lucky to be alive after she was stung by a deadly box jellyfish at a remote beach in Milingimbi in the Northern Territory, Australia.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013047521 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Layne Keliiokalam Kamalu |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1104987916 PECOS PAC ID: 9335048701 Enrollment ID: I20051116000272 |
News Archive
Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.
Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
Chemists funded by NIH's National Institute of General Medical Sciences are working to develop "greener" processes for discovering, developing and manufacturing medicines and other molecules with therapeutic potential, as well as compounds used in biomedical research.
A new University of Sydney study has found that having Type 1 diabetes alters the normal communication between the human central nervous system and bone marrow, causing inflammatory effects and further disease.
A three year old girl is lucky to be alive after she was stung by a deadly box jellyfish at a remote beach in Milingimbi in the Northern Territory, Australia.
› Verified 3 days ago
| Provider Name | Cara Mellor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932396280 PECOS PAC ID: 7810077948 Enrollment ID: I20080102000397 |
News Archive
Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.
Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
Chemists funded by NIH's National Institute of General Medical Sciences are working to develop "greener" processes for discovering, developing and manufacturing medicines and other molecules with therapeutic potential, as well as compounds used in biomedical research.
A new University of Sydney study has found that having Type 1 diabetes alters the normal communication between the human central nervous system and bone marrow, causing inflammatory effects and further disease.
A three year old girl is lucky to be alive after she was stung by a deadly box jellyfish at a remote beach in Milingimbi in the Northern Territory, Australia.
› Verified 3 days ago
News Archive
Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.
Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
Chemists funded by NIH's National Institute of General Medical Sciences are working to develop "greener" processes for discovering, developing and manufacturing medicines and other molecules with therapeutic potential, as well as compounds used in biomedical research.
A new University of Sydney study has found that having Type 1 diabetes alters the normal communication between the human central nervous system and bone marrow, causing inflammatory effects and further disease.
A three year old girl is lucky to be alive after she was stung by a deadly box jellyfish at a remote beach in Milingimbi in the Northern Territory, Australia.
› Verified 3 days ago
Davis North Gastroenterology Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2084 Robins Dr, Suite B, Layton, UT 84041 Phone: 801-773-9710 Fax: 801-773-9944 | |
Work Care-north, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2084 N 1700 W #d, Layton, UT 84041 Phone: 801-773-3400 Fax: 801-773-3401 | |
Layton Family Speciality Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2950 N Church Street, Layton, UT 84040 Phone: 801-546-9441 | |
After Hours Medical - Layton Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1550 N Main St, Suite C, Layton, UT 84041 Phone: 801-525-1100 Fax: 801-525-1114 | |
Uuhc - Davis Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1492 W Antelope Dr Ste 150, Layton, UT 84041 Phone: 801-776-7804 | |
Utah Home Health And Hospice Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 920 W Heritage Park Blvd Suite 120, Layton, UT 84041 Phone: 801-335-6455 Fax: 801-377-2386 |